Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.93 |
| ▸ | RECQL | P46063 | 2/20 | 0.93 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.89 |
| ▸ | MEN1 | O00255 | 2/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.89 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.89 |
| ▸ | USP2 | O75604 | 1/20 | 0.89 |
| ▸ | POLB | P06746 | 1/20 | 0.89 |
| ▸ | MAPT | P10636 | 1/20 | 0.89 |
| ▸ | HPGD | P15428 | 1/20 | 0.89 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.89 |
| ▸ | BLM | P54132 | 1/20 | 0.89 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.89 |
| ▸ | HMGCR | P04035 | 3/20 | 0.89 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.65 |
| ▸ | PPARG | P37231 | 6/20 | 0.65 |
| ▸ | PPARD | Q03181 | 6/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28742735 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL28742727 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL31189074 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL31189030 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL10919700 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL4863654 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL47069 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL11525377 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL2733500 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 | |
| SCHEMBL28742745 | 1.00 | TDP1 (0.93) | TDP1RECQLPTPN7ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| US-20190054186-A1 | Magnetic Nanoparticle-Polymer Complexes and uses Thereof | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2019-02-21 | — | — | US | disclosed |
| WO-2017173205-A1 | MAGNETIC NANOPARTICLE-POLYMER COMPLEXES AND USES THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2017-10-05 | — | — | WO | disclosed |
| US-8415400-B2 | Synthesizing an amphiphilic block polymer micelle having ionically-charged polymeric segments and nonionically-charged polymeric segments; neutralizing under conditions that allow for self-assembly of polymer micelles; crosslinking; removing the moieties of opposite charge; drug delivery; stability | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2013-04-09 | — | — | US | disclosed |
| US-8263558-B2 | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | ABBOTT LABORATORIES (US) | 2012-09-11 | — | — | US | disclosed |
| EP-2150820-A1 | ANALYSIS METHOD | Surescreen Diagnostics Limited (GB) | 2010-02-10 | — | — | EP | disclosed |
| US-20100016392-A1 | Pesticidal Aggregates | INNOVAFORM TECHNOLOGIES, LLC (US) | 2010-01-21 | — | — | US | disclosed |
| US-20090214515-A1 | METHODS OF PREPARATION OF RECOMBINANT FORMS OF HUMAN BETA-AMYLOID PROTEIN AND USES OF THESE PROTEINS | ABBVIE DEUTSCHLAND GMBH & CO KG (DE) | 2009-08-27 | — | — | US | disclosed |
| EP-2091323-A2 | PESTICIDAL AGGREGATES | Innovaform Technologies, LLC (US) | 2009-08-26 | — | — | EP | disclosed |
| US-7056532-B1 | Compositions for delivery of biological agents and methods for the preparation thereof | Univ. Nebraska Bd. of Regents (US) | 2006-06-06 | — | — | US | disclosed |
| EP-1005324-B1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIV NEBRASKA (US) | 2005-03-30 | — | — | EP | disclosed |
| US-20040228823-A1 | Cross-linked ionic core micelles | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 2004-11-18 | — | — | US | disclosed |
| US-6696089-B2 | CROSS-LINKED POLYIONIC POLYMER FRAGMENT AND AT LEAST ONE NONIONIC WATER-SOLUBLE POLYMER FRAGMENT | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2004-02-24 | — | — | US | disclosed |
| WO-2003082348-A1 | NANOGEL NETWORKS INCLUDING POLYION POLYMER FRAGMENTS AND BIOLOGICAL AGENT COMPOSITIONS THEREOF | SUPRATEK PHARMA INC. (CA) | 2003-10-09 | — | — | WO | disclosed |
| US-6525058-B1 | 1-ethyl methylester 4-((3- (p-(carboxyamidino)phenyl) -2-oxo-5-oxazolidinyl)methyl)-1-piperazineacetate; Gantofiban; antagonistic action to Glycoprotein GPIIb/IIIa receptor; oily base; gantofiban citrate | YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) | 2003-02-25 | — | — | US | disclosed |
| US-20020136769-A1 | Cross-linked polyionic polymer fragment and at least one nonionic water-soluble polymer fragment | BOARD OF REGENTS OF THE UNIVERSITYH OF NEBRASKA | 2002-09-26 | — | — | US | disclosed |
| EP-1188440-A1 | MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2002-03-20 | — | — | EP | disclosed |
| US-6333051-B1 | FOR COMBINATORIAL DRUG DELIVERY, OR COMBINATORIAL FORMULATION | SUPRATEK PHARMA, INC. (CA) | 2001-12-25 | — | — | US | disclosed |
| WO-1998056348-A1 | COMPOSITIONS FOR DELIVERY OF BIOLOGICAL AGENTS AND METHODS FOR THE PREPARATION THEREOF | UNIVERSITY OF NEBRASKA BOARD OF REGENTS (US) | 1998-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020136769-A1 | Cross-linked polyionic polymer fragment and at least one nonionic water-soluble polymer fragment | PUF60, CD44, PCLAF | TDP1 2044/4885RECQL 3604/4885PTPN7 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.